Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer (ENDORAD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
ARCAGY/ GINECO GROUP
ClinicalTrials.gov Identifier:
NCT00870337
First received: March 26, 2009
Last updated: October 28, 2014
Last verified: October 2014